Table 3 Incidences of adverse drug reactions in patients with chemotherapy-induced peripheral neuropathy in the MiroCIP interventional study (safety analysis set)
ADRa | n (%) |
|---|---|
Overall | 16 (30.8) |
Occurring in ≥ 1 patient | |
 Somnolence | 7 (13.5) |
 Dizziness | 5 (9.6) |
 Oedema peripheral | 2 (3.8) |
 Abdominal discomfort | 1 (1.9) |
 Altered state of consciousness | 1 (1.9) |
 Fall | 1 (1.9) |
 Hepatic function abnormal | 1 (1.9) |
 Liver disorder | 1 (1.9) |
 Loss of consciousness | 1 (1.9) |
 Thirst | 1 (1.9) |
Serious ADRs | 0 (0.0) |
Discontinuation due to ADRs | 6 (11.5)b |
Death | 0 (0.0) |